427 related articles for article (PubMed ID: 33597603)
1. Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment.
Chai YL; Chong JR; Raquib AR; Xu X; Hilal S; Venketasubramanian N; Tan BY; Kumar AP; Sethi G; Chen CP; Lai MKP
Sci Rep; 2021 Feb; 11(1):4010. PubMed ID: 33597603
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
3. Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population.
Gyanwali B; Shaik MA; Venketasubramanian N; Chen C; Hilal S
J Alzheimers Dis; 2019; 71(4):1309-1320. PubMed ID: 31524167
[TBL] [Abstract][Full Text] [Related]
4. Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.
Zhu Y; Chai YL; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CP; Lai MK
Alzheimers Dement (Amst); 2017; 7():41-47. PubMed ID: 28239640
[TBL] [Abstract][Full Text] [Related]
5. Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia.
Wu LY; Cheah IK; Chong JR; Chai YL; Tan JY; Hilal S; Vrooman H; Chen CP; Halliwell B; Lai MKP
Free Radic Biol Med; 2021 Dec; 177():201-211. PubMed ID: 34673145
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia.
Chai YL; Hilal S; Chong JPC; Ng YX; Liew OW; Xu X; Ikram MK; Venketasubramanian N; Richards AM; Lai MKP; Chen CP
Medicine (Baltimore); 2016 Aug; 95(33):e4566. PubMed ID: 27537582
[TBL] [Abstract][Full Text] [Related]
7. Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
Wu LY; Chong JR; Chong JPC; Hilal S; Venketasubramanian N; Tan BY; Richards AM; Chen CP; Lai MKP
J Alzheimers Dis; 2024; 97(3):1289-1298. PubMed ID: 38217598
[TBL] [Abstract][Full Text] [Related]
8. Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort.
Chia RSL; Minta K; Wu LY; Salai KHT; Chai YL; Hilal S; Venketasubramanian N; Chen CP; Chong JR; Lai MKP
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254675
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment.
Chua XY; Chai YL; Chew WS; Chong JR; Ang HL; Xiang P; Camara K; Howell AR; Torta F; Wenk MR; Hilal S; Venketasubramanian N; Chen CP; Herr DR; Lai MKP
Alzheimers Res Ther; 2020 Sep; 12(1):122. PubMed ID: 32998767
[TBL] [Abstract][Full Text] [Related]
10. Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease.
Xu X; Phua A; Collinson SL; Hilal S; Ikram MK; Wong TY; Cheng CY; Venketasubramanian N; Chen C
Stroke Vasc Neurol; 2019 Sep; 4(3):135-140. PubMed ID: 31709119
[TBL] [Abstract][Full Text] [Related]
11. Global cerebrovascular burden and long-term clinical outcomes in Asian elderly across the spectrum of cognitive impairment.
Xu X; Chan YH; Chan QL; Gyanwali B; Hilal S; Tan BY; Ikram MK; Venketasubramanian N; Chen CL
Int Psychogeriatr; 2018 Sep; 30(9):1355-1363. PubMed ID: 29665875
[TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular disease in suspected non-Alzheimer's pathophysiology and cognitive decline over time.
Saridin FN; Chew KA; Reilhac A; Gyanwali B; Villaraza SG; Tanaka T; Scheltens P; van der Flier WM; Chen CLH; Hilal S
Eur J Neurol; 2022 Jul; 29(7):1922-1929. PubMed ID: 35340085
[TBL] [Abstract][Full Text] [Related]
13. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis.
Custodero C; Ciavarella A; Panza F; Gnocchi D; Lenato GM; Lee J; Mazzocca A; Sabbà C; Solfrizzi V
Geroscience; 2022 Jun; 44(3):1373-1392. PubMed ID: 35486344
[TBL] [Abstract][Full Text] [Related]
14. Markers of cardiac dysfunction in cognitive impairment and dementia.
Hilal S; Chai YL; Ikram MK; Elangovan S; Yeow TB; Xin X; Chong JY; Venketasubramanian N; Richards AM; Chong JPC; Lai MKP; Chen C
Medicine (Baltimore); 2015 Jan; 94(1):e297. PubMed ID: 25569645
[TBL] [Abstract][Full Text] [Related]
15. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
Chong JR; Ashton NJ; Karikari TK; Tanaka T; Saridin FN; Reilhac A; Robins EG; Nai YH; Vrooman H; Hilal S; Zetterberg H; Blennow K; Lai MKP; Chen CP
Alzheimers Dement; 2021 Oct; 17(10):1649-1662. PubMed ID: 33792168
[TBL] [Abstract][Full Text] [Related]
16. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of vascular cognitive impairment and dementia.
Erkinjuntti T
J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
[TBL] [Abstract][Full Text] [Related]
18. Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia.
Zhu Y; Hilal S; Chai YL; Ikram MK; Venketasubramanian N; Chen CP; Lai MKP
Front Aging Neurosci; 2018; 10():8. PubMed ID: 29410622
[No Abstract] [Full Text] [Related]
19. Subcortical Atrophy in Cognitive Impairment and Dementia.
Hilal S; Amin SM; Venketasubramanian N; Niessen WJ; Vrooman H; Wong TY; Chen C; Ikram MK
J Alzheimers Dis; 2015; 48(3):813-23. PubMed ID: 26402115
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological assessment and cerebral vascular disease: the new standards.
Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
